Sanjivani Paranteral Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Sanjivani Paranteral Ltd is ₹ 133.75 as of 18 May 15:30 . The p/e ratio of Sanjivani Paranteral Ltd changed from 28.4 to 35.2 over 2 quarters. This represents a CAGR of 53.62% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 4 quarters. This represents a CAGR of -100.00% The market cap of Sanjivani Paranteral Ltd changed from ₹ 175.32 crore to ₹ 284.8 crore over 2 quarters. This represents a CAGR of 163.89% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The revenue of Sanjivani Paranteral Ltd for the Mar '26 is ₹ 13.81 crore as compare to the Dec '25 revenue of ₹ 22.36 crore. This represent the decline of -38.24% The revenue of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanjivani Paranteral Ltd for the Mar '26 is ₹ 2.17 crore as compare to the Dec '25 ebitda of ₹ 4.13 crore. This represent the decline of -47.46% The ebitda of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sanjivani Paranteral Ltd changed from ₹ 1.71 crore to ₹ 0.55 crore over 8 quarters. This represents a CAGR of -43.29% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The dividend payout of Sanjivani Paranteral Ltd changed from 7.33 % to 7.33 % over 1 quarters. This represents a CAGR of 0.00% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Sanjivani Paranteral Ltd

Sanjivani Paranteral Limited is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades.
The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a Public Limited Company in October, 1994, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry.
The Company is involved in the manufacturing of pharmaceutical medicines.
Its products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Sanjivani Paranteral Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Sanjivani Paranteral Ltd or Sanofi India Ltd?

Market cap of Sanjivani Paranteral Ltd is 164 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Sanjivani Paranteral Ltd and Sanofi India Ltd?

The stock performance of Sanjivani Paranteral Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanjivani Paranteral Ltd and Sanofi India Ltd?

As of May 18, 2026, the Sanjivani Paranteral Ltd stock price is INR ₹133.75. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Sanjivani Paranteral Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Sanjivani Paranteral Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.